Health
Antigenic “supersite” could improve design of COVID-19 vaccines – News-Medical.Net
Researchers in the United States have defined an antigenic “supersite” within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could…
Researchers in the United States have defined an antigenic “supersite” within the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could have important implications for the design of vaccines to protect against coronavirus disease 2019 (COVID-19).
The site was identified on the N-terminal domain (NTD) of the viral spike protein – the main structure the virus uses to bind and infect host cells.
The team – from Columbia University and the National Institute of Allergy and Infectious…
-
Noosa News22 hours agoFull house as Minister shares vision for Sunshine Coast transport
-
General20 hours agoDash cam video shows spectacular Finke Desert Race crash
-
Business20 hours agoWhy I’d buy these top ASX 200 shares next
-
Noosa News19 hours agoDocPlay Is Streaming 11 Documentaries About Indigenous and Torres Strait Islander Culture for Free for NAIDOC Week 2025